SEMA3A and hepatocellular carcinoma: In addition, when we treated the CM derived from HCC cells with a high level of Sema3A (PLC/PRF/5-Sema3A and HCCLM3-Mock) with anti-Sema3A neutralizing antibody, the chemotactic response of macrophage decreased.